In Western Europe, the average return on equity (ROE) in the health & pharmaceuticals sector was around 0.75 percent. As of January 2023, companies in the pharmaceutical drugs industry in Western Europe saw average returns on equity of approximately 21.6 percent, as compared to biotechnology drugs firms which saw ROE of negative 14.7 percent.
Return on equity is an important measure of a company's profitability. ROE is calculated by taking the amount of net income returned as a percentage of the shareholders equity. Return on equity looks at how well a company’s management is using its assets to create profits.
Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry
Western Europe.
Values are as of January each year.
A total of 746 companies were included in the calculation for 2023.
The source added the following information "Estimated by dividing the net income by the book value of equity. The source used cumulated values for both variables, for the sector, to estimate the sector ROE. If book value of equity is negative, this is not estimated. (For non-cash ROE, see Non-cash ROE)".
Figures for years 2019 to 2022 were previously published by the source.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2023). Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/
Leonard N. Stern School of Business. "Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry." Chart. January 5, 2023. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/
Leonard N. Stern School of Business. (2023). Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/
Leonard N. Stern School of Business. "Average Return on Equity (Roe) in The Health & Pharmaceuticals Sector in Western Europe from 2019 to 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/
Leonard N. Stern School of Business, Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry Statista, https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/ (last visited December 21, 2024)
Average return on equity (ROE) in the health & pharmaceuticals sector in Western Europe from 2019 to 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1043972/return-on-equity-in-the-health-and-pharmaceuticals-in-europe/
